Page last updated: 2024-08-23

tetradecanoylphorbol acetate and ursodeoxycholic acid

tetradecanoylphorbol acetate has been researched along with ursodeoxycholic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Güldütuna, S; Leuschner, U; Sipos, P; Vallent, K1
Bouscarel, B; Dubner, H; Fromm, H; Gettys, TW1
Handa, H; Hiramoto, M; Hirano, F; Makino, I; Makino, Y; Okamoto, K; Tanada, H1
Inaba, K; Ishikawa, H; Kashima, K; Matsumoto, M; Mitsuyoshi, H; Nakajima, Y; Nakashima, T; Okanoue, T; Sakamoto, Y1
Gohda, E; Hiramatsu, K; Matsumoto, Y; Miyazaki, M; Tsubouchi, H; Yamamoto, I1
Kelleher, D; Long, A; Looby, E; Shah, SA; Volkov, Y1

Trials

1 trial(s) available for tetradecanoylphorbol acetate and ursodeoxycholic acid

ArticleYear
[Comparative study of superoxide production of monocytes in primary biliary cirrhosis].
    Orvosi hetilap, 1995, Oct-29, Volume: 136, Issue:44

    Topics: Anions; Cholagogues and Choleretics; Cholelithiasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Monocytes; Superoxides; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid

1995

Other Studies

5 other study(ies) available for tetradecanoylphorbol acetate and ursodeoxycholic acid

ArticleYear
Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC.
    The American journal of physiology, 1995, Volume: 268, Issue:2 Pt 1

    Topics: Angiotensin II; Animals; Bile Acids and Salts; Calcium; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Liver; Male; Mesocricetus; Protein Kinase C; Receptors, Glucagon; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid

1995
Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids.
    Carcinogenesis, 1996, Volume: 17, Issue:3

    Topics: Activating Transcription Factor 1; Adenocarcinoma; Base Sequence; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholic Acid; Cholic Acids; Colonic Neoplasms; Deoxycholic Acid; DNA Primers; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Activation; Gene Expression Regulation; Genetic Vectors; Humans; Lithocholic Acid; Molecular Sequence Data; NF-kappa B; Podophyllin; Podophyllotoxin; Protein Kinase C; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Ursodeoxycholic Acid

1996
Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes.
    Biochemical and biophysical research communications, 1997, Nov-26, Volume: 240, Issue:3

    Topics: Animals; Biomarkers; Calcimycin; Cells, Cultured; Dactinomycin; Dexamethasone; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Ionophores; Liver; Male; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger; Sphingosine; Tetradecanoylphorbol Acetate; Tyrosine Transaminase; Up-Regulation; Ursodeoxycholic Acid

1997
Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid.
    Biological & pharmaceutical bulletin, 2005, Volume: 28, Issue:4

    Topics: Cell Line; Cholera Toxin; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Gene Expression; Hepatocyte Growth Factor; Humans; Mitogen-Activated Protein Kinases; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid

2005
Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:14

    Topics: Anticarcinogenic Agents; Blotting, Western; Cell Line, Tumor; Cell Shape; Colonic Neoplasms; Deoxycholic Acid; Green Fluorescent Proteins; Humans; Protein Kinase C; Tetradecanoylphorbol Acetate; Transfection; Ursodeoxycholic Acid

2005